Apollomics Insider Trades
NASDAQ: APLMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $8.25M
- Sales
- 0 · $0
- Shares bought / sold
- 583.33K / 0
- Net activity
- Net buying $8.3 million
Apollomics insider activity
Over the last 12 months, Apollomics insiders reported 28 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $8.3 million and sold $0 worth of stock, for net insider buying of $8.3 million. The most recent filing shows Huang Ya-Chi (Director) reporting a transaction in 500 shares on Nov 17, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put APLM's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
APLM insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 17, 2026 | Huang Ya-ChiDirector | Option exercise | 500 | — | Form 4 |
| Sep 15, 2026 | Yen Hung HsienDirector | Option exercise | 500 | — | Form 4 |
| Sep 15, 2026 | TSAI HSIEN-SHUDirector | Option exercise | 500 | — | Form 4 |
| Sep 15, 2026 | Chen Hung-WenChief Executive Officer | Option exercise | 5,000 | — | Form 4 |
| Sep 15, 2026 | Chen Yi-KueiChief Operating Officer | Option exercise | 5,000 | — | Form 4 |
| Sep 15, 2026 | CHEN HONG-JUNGDirector | Option exercise | 500 | — | Form 4 |
| Sep 15, 2026 | LIN PETER KUAN-HOWChief Financial Officer | Tax withholding | 3,416 | $82.05K | Form 4 |
| Sep 15, 2026 | LIN PETER KUAN-HOWChief Financial Officer | Option exercise | 10,000 | — | Form 4 |
| Sep 15, 2026 | Yen Hung HsienDirector | Option exercise | 500 | — | Form 4 |
| Sep 15, 2026 | Chen Yi-KueiChief Operating Officer | Option exercise | 5,000 | — | Form 4 |
| Sep 15, 2026 | LIN PETER KUAN-HOWChief Financial Officer | Tax withholding | 3,416 | $82.05K | Form 4 |
| Sep 15, 2026 | LIN PETER KUAN-HOWChief Financial Officer | Option exercise | 10,000 | — | Form 4 |
| Aug 17, 2026 | Huang Ya-ChiDirector | Option exercise | 500 | — | Form 4 |
| Aug 14, 2026 | Chen Hung-WenChief Executive Officer | Buy | 266,667 | $4.00M | Form 4 |
| Aug 14, 2026 | Chen Hung-WenChief Executive Officer | Buy | 103,333 | $1.55M | Form 4 |
| Aug 14, 2026 | Chen Hung-WenChief Executive Officer | Buy | 166,667 | $2.00M | Form 4 |
| Aug 14, 2026 | Chen Yi-KueiChief Operating Officer | Buy | 20,000 | $300.00K | Form 4 |
| Aug 14, 2026 | LIN PETER KUAN-HOWChief Financial Officer | Buy | 26,667 | $400.00K | Form 4 |
| Jun 15, 2026 | Jan Chen-HuanDirector | Option exercise | 500 | — | Form 4 |
| Jun 15, 2026 | Chen Yi-KueiChief Operating Officer | Option exercise | 5,000 | — | Form 4 |
| Jun 15, 2026 | TSAI HSIEN-SHUDirector | Option exercise | 500 | — | Form 4 |
| Jun 15, 2026 | CHU YI-ANDirector | Option exercise | 500 | — | Form 4 |
| Jun 15, 2026 | CHEN HONG-JUNGDirector | Option exercise | 500 | — | Form 4 |
| Jun 15, 2026 | Chen Hung-WenChief Executive Officer | Option exercise | 5,000 | — | Form 4 |
| Jun 15, 2026 | LIN PETER KUAN-HOWChief Financial Officer | Tax withholding | 3,588 | $49.69K | Form 4 |
| Jun 15, 2026 | LIN PETER KUAN-HOWChief Financial Officer | Option exercise | 10,000 | — | Form 4 |
| May 17, 2026 | Huang Ya-ChiDirector | Option exercise | 500 | — | Form 4 |
| Mar 31, 2026 | LIN PETER KUAN-HOWChief Financial Officer | Tax withholding | 3,582 | $56.77K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4